Dr. Jiachang Tan 谭家昌
Chief Physician
Department of Bone and Soft Tissue Surgery, Guangxi Medical University Cancer Hospital, Nanning
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Treatment of osteosarcoma, Ewing sarcoma, giant cell tumor of bone, spinal metastases, pelvic tumors, and soft tissue malignancies. Specializes in chemotherapy and surgical resection with reconstruction for malignant bone and soft tissue tumors.
Dr. Tan holds a medical doctorate and serves as a Chief Physician in orthopedic surgery and master’s supervisor. The doctor leads one department-level and one city-level research project, having participated in multiple national and provincial studies. Dr. Tan has published over 30 academic papers, including 8 indexed by SCI, and received four third-prize awards for promoting appropriate medical technologies in Guangxi.
Professional roles
- Member, Innovation and Translational Medicine Group, Sarcoma Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Bone and Soft Tissue Tumor Professional Committee, Guangxi Anti-Cancer Association
- Standing Committee Member, Pediatric Orthopedics Group, Guangxi Medical Doctor Association
- Member, Tumor Marker Professional Committee, Guangxi Anti-Cancer Association
Name order: in Chinese the family name comes first (Tan Jiachang). Papers usually list the name as Jiachang Tan or Tan J.
Selected publications
5 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Oncol, 2025 (senior author): The utilization of 3D-printed arthrodesis prostheses in the repair and reconstruction of malignant tumors in proximal humerus. PubMed 40606979
- 3D Print Med, 2025 (senior author): Treatment of distal radius giant cell tumor with 3D-printed metal prosthesis combined with mesh patch. PubMed 40140227
- Biomed Pharmacother, 2020 (first author): Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma. PubMed 32179199
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion